• BioTime Reports Second Quarter 2019 Financial Results and Provides Business Update

    ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel …

    Read More
  • 0 0